<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMN</journal-id><journal-title-group><journal-title>Open Journal of Modern Neurosurgery</journal-title></journal-title-group><issn pub-type="epub">2163-0569</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmn.2023.132010</article-id><article-id pub-id-type="publisher-id">OJMN-124459</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Brain Abscess Surgery Outcome: A Comparison between Craniotomy with Membrane Excision versus Burr Hole Aspiration
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Babiker</surname><given-names>Sirelkhatim Hassan Ali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abubakr</surname><given-names>Darrag Salim Ahmed</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohammed</surname><given-names>Awad Elzain</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fawaz</surname><given-names>Eljili Marhoom Abdelradi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Ribat University Hospital, Neurospine Center, Khartoum, Sudan</addr-line></aff><aff id="aff1"><addr-line>Department of Neurosurgery, National Center for Neurological Sciences, Khartoum, Sudan</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>04</month><year>2023</year></pub-date><volume>13</volume><issue>02</issue><fpage>74</fpage><lpage>93</lpage><history><date date-type="received"><day>7,</day>	<month>November</month>	<year>2022</year></date><date date-type="rev-recd"><day>21,</day>	<month>April</month>	<year>2023</year>	</date><date date-type="accepted"><day>24,</day>	<month>April</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Brain abscess represents 8% of intracranial masses in developing countries. Despite the advances in neuro-imaging, still, the diagnosis of brain abscess is difficult and may need a biopsy in most cases to verify the diagnosis because may even lead to death. CT scan with contrast is a good tool for diagnosing and localizing brain abscesses in late stages, however, it is difficult to diagnose them in the early stages. The development of MRI helps to more accurately diagnose brain abscess. Surgical management of brain abscesses is either medical or surgical through craniotomy or burr holes. Indications of each are still a point of debate among most neurosurgeons. 
  Methodology: This is a descriptive longitudinal prospective study to compare the outcomes of two surgical procedures used in The National Centre for Neurological Sciences-Khartoum-Sudan (NCNS) from 2012 to 2015, craniotomy and excision of the abscess membrane versus burr hole and aspiration of brain abscess in terms of duration of hospitalization, length of antibiotic use, recurrence rate, number of images needed for follow-up, and the final postoperative early and late outcomes. The data was collected through a designed questionnaire and was then analyzed using SPSS version 20. No significant ethical approval was required for this study. 
  Results: Fifty-four patients were operated on through craniotomy (29/54) and burr hole (25/54). Their ages ranged from 1 year to 53 years with an average presentation at 13 years of age. Most patients presented with fever (23.1%), convulsions (16%), vomiting (16.7%) and headache (15.4%). The mean of illness for both groups was almost 2 months. The majority of patients in this study were having no risk factors (38.9%) while the major risk factors seen were cardiac diseases (14.8%), neurosurgical procedures (13%) and otitis media (11.1%). As most patients presented late, the diagnosis of most was made using CT brain with contrast (83.3%). In most of the patients (85.2%) there were no organisms separated in the culture. 8/54 patients had positive cultures, 7/8 were bacterial and only one (1/8) was fungal. Most patients received antibiotics for 45 days postoperatively in both craniotomy and burr hole groups. When both groups were compared, those operated with craniotomy were found to have a relatively higher length of hospital stay, however, no significant difference was found between both groups. Also, it was found that those operated on with craniotomy had a high cure rate and less recurrence in comparison with burr hole group. Deterioration and death were significantly higher among craniotomy group. Only CT brain was used as the imaging modality of choice for follow-up in both groups for 4 months’ duration and it was noted that complete evacuation was significantly higher among craniotomy group while remnants were higher among burr hole group. 
  Conclusion: Brain abscess is still a challenging condition for neurosurgeons in Sudan. The limited number of Sudanese neurosurgeons, neurosurgical centers and diagnostic facilities contributed to delay in diagnosing brain abscess in most patients. It is important to design a strict protocol and precautions for any neurosurgical operation or bedside procedure to prevent infection and subsequent brain abscess development. CT brain with contrast is a good imaging tool for assessing the size, site and stage of brain abscesses. No significant difference between craniotomy or burr hole for clearance from brain abscess in terms of antibiotic used or duration of hospital stay. However, burr hole aspiration is associated with higher rates of recurrences. On the other hand, craniotomy and excision have relatively higher neurologic morbidity postoperative with expectantly higher post-operative hospitalization but no differences in the final outcome. Therefore, the selection of surgical technique should be individualized in each case based on the abscess site size source patient fitness for surgery and neurosurgeon’s preference.
 
</p></abstract><kwd-group><kwd>Brain Abscess Surgery</kwd><kwd> Outcome</kwd><kwd> Comparison of Surgery of Brain Abscess</kwd><kwd> Craniotomy versus Burrhole</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>A brain abscess is an intraparenchymal pus collection. The occurrence of brain abscesses is about 8% of intracranial masses in developing countries, and 1% - 2% in developed countries. [<xref ref-type="bibr" rid="scirp.124459-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref2">2</xref>] Brain abscesses start as localized areas of cerebritis in the brain parenchyma and develop into collections of pus surrounded by a well-vascularized capsule. Despite there having been innovative advances in clinical Neuro-imaging techniques, Neurosurgical techniques, Neuroanesthesia, Microbiological isolation techniques and antibiotic therapy, brain abscesses can be fatal [<xref ref-type="bibr" rid="scirp.124459-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref6">6</xref>] . A multidisciplinary approach is predominant to the successful management of brain abscesses and is a team approaches that include Neurosurgery, Neuro-medicine, Neuroradiology, and an infectious disease department.</p><p>Intracranial abscess formation is a direct interaction between the virulence of the affront microorganism and the immune response of the host. It is still a severe, life-threatening disease and remains a conceivably fatal entity. [<xref ref-type="bibr" rid="scirp.124459-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref7">7</xref>] It may lead to severe disability, or even death if misdiagnosed or managed inappropriately. However, the approach of current neurosurgical techniques including burr hole and aspiration or craniotomy and membrane excision with culture techniques, new generation antibiotics, and modern non-invasive neuroradiological imaging procedures have revolutionized the treatment and outcome of brain abscess. Eradication of the primary foci of infection is a chief. [<xref ref-type="bibr" rid="scirp.124459-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref9">9</xref>] The success of treatment is best when the etiologic agent is identified and antimicrobial therapy is targeted. The causative pathogens of brain abscesses vary according to geographic location, age, underlying medical and/or surgical condition, and mode of infection. [<xref ref-type="bibr" rid="scirp.124459-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref12">12</xref>]</p><p>Over the period of the last two decades, the incidence of the otogenic abscess has reduced while the post-traumatic or postoperative brain abscess has increased. [<xref ref-type="bibr" rid="scirp.124459-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref15">15</xref>]</p></sec><sec id="s2"><title>2. Methodology</title><p>This is a descriptive longitudinal prospective study to compare the outcomes of two surgical procedures used for the treatment of brain abscess either via craniotomy with excision of membrane or via burr hole with an aspiration of the abscess. The study is conducted at The National Center for Neurological Sciences-Khartoum-Sudan (NCNS) including all patients who presented and were diagnosed with brain abscess and underwent surgery either craniotomy or burr hole with aspiration during the period from 2012 to 2015. The inclusion criteria represent all patients diagnosed with brain abscess in the (NCNS) during the mentioned period who underwent intervention either by craniotomy or burr hole. Exclusion criteria were patients without a confirmed diagnosis of brain abscess; those who were diagnosed with brain abscess and not treated surgically or operated on in other hospitals other than (NCNS). Data is collected by structured questionnaire sheet. The comparison was about the duration of hospitalization, length of antibiotic use, recurrence rate, number of images needed for follow-up and the final outcome. No significant ethical approval was required for this study because it is just an observational descriptive study for that outcome of two surgical procedures that are already used in this discipline and no new intervention was done to the selected participants by the researcher and no break to the patient’s confidentiality and privacy</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Age Distribution</title><p>The youngest patient was 1-year-old and the oldest was 53 years old and the average age at presentation was approximately 12 years old (<xref ref-type="table" rid="table1">Table 1</xref>(a)) while the most affected age group was from 1 - 10 years (55.6%) (<xref ref-type="table" rid="table1">Table 1</xref>(b)).</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> (a) The statistical values of age distribution among this series; (b) The age distribution in groups</title></caption><table-wrap id="1_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >12.72</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >7.50</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >52</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >53</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age in Groups</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >1 - 10 years</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >55.6%</td></tr><tr><td align="center" valign="middle" >11 - 20 years</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >22.2%</td></tr><tr><td align="center" valign="middle" >21 - 30 years</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7.4%</td></tr><tr><td align="center" valign="middle" >More than 30 years</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14.8%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap></table-wrap-group></sec><sec id="s3_2"><title>3.2. Sex Distribution</title><p>Most of the patients were males (63%) and one-third were females (37%), (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_3"><title>3.3. Geographic Distribution</title><p>For ease of description, the patients were divided among 5 main regions according to their region of origin. The majority of them were found in Khartoum and the central area (72.2%) (<xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_4"><title>3.4. Diagnosis</title><p>All of the patients were diagnosed with brain abscess pre-operatively.</p></sec><sec id="s3_5"><title>3.5. Period between Diagnosis and Surgery</title><p>Most patients spent approximately 25 days between diagnosis and brain abscess surgery. Two patients were operated on the same day of diagnosis, while 2 patients spent approximately one year (<xref ref-type="table" rid="table4">Table 4</xref>(a)). The average duration was found to be ranging between 0 - 20 days (79.6%) (<xref ref-type="table" rid="table4">Table 4</xref>(b)).</p></sec><sec id="s3_6"><title>3.6. Main Complaint</title><p>Most patients presented with fever, convulsions, vomiting and headache while only a few of them presented with motor weakness. (<xref ref-type="table" rid="table5">Table 5</xref>(a)) Those who had other symptoms most of them presented with aphasia and ear discharge (<xref ref-type="table" rid="table5">Table 5</xref>(b)).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The gender distribution</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Gender</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >63.0%</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >37.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> The geographical distribution of the patients according to the area of origin</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Residence</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Khartoum</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >35.2%</td></tr><tr><td align="center" valign="middle" >Central Area</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >37.0%</td></tr><tr><td align="center" valign="middle" >North</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.6%</td></tr><tr><td align="center" valign="middle" >South</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >West</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >20.4%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap-group id="4"><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> (a) The statistical values of the duration in days between the diagnosis and surgical intervention; (b) The duration between diagnosis and surgical intervention in groups</title></caption><table-wrap id="4_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >25.74</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >9.00</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >374</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >374</td></tr></tbody></table></table-wrap><table-wrap id="4_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Period between Diagnosis and Surgery</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >0 - 20 days</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >79.6%</td></tr><tr><td align="center" valign="middle" >21 - 40 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >11.1%</td></tr><tr><td align="center" valign="middle" >41 - 60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >More than 60</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7.4%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap></table-wrap-group></sec><sec id="s3_7"><title>3.7. Duration of Illness in Days</title><p>The minimum duration of illness among this series was 2 weeks while the maximum duration was 13 months. The majority of patients presented in 2 months’ duration (<xref ref-type="table" rid="table6">Table 6</xref>(a)). When the duration was put in groups, the majority of cases were lying in periods ranging from 21 - 60 days (61.1%) (<xref ref-type="table" rid="table6">Table 6</xref>(b)).</p><table-wrap-group id="5"><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> (a) The distribution of the main presenting complaint; (b) Other presenting complaints; the distribution of the other complaints among the affected groups</title></caption><table-wrap id="5_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Main Complain</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Headache</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >15.4%</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >16.7%</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >23.1%</td></tr><tr><td align="center" valign="middle" >Motor Weaknesses</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >10.9%</td></tr><tr><td align="center" valign="middle" >Convulsion</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >16%</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >17.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >156</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap><table-wrap id="5_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Other Complains</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Aphasia</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >21.4%</td></tr><tr><td align="center" valign="middle" >Squint and Eye Swelling</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Complete Blindness</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Blurring of Vision</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Confusion</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Decreased Level of Consciousness</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >10.7%</td></tr><tr><td align="center" valign="middle" >Impaired Vision</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Ear Discharge</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17.8%</td></tr><tr><td align="center" valign="middle" >Ear Pain</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Exposed V. P. Shunt</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Increased Head Size</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Facial Palsy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Refusal of Feeding</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Unsteady Gait, Dizziness &amp; Decreased Hearing</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.6%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="6"><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> (a) The statistical values of the duration of patient illness in days; (b) The distribution of the duration of patient illness in groups</title></caption><table-wrap id="6_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >62.83</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >44.50</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >386</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >400</td></tr></tbody></table></table-wrap><table-wrap id="6_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration in Groups</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >1 - 20 days</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14.8%</td></tr><tr><td align="center" valign="middle" >21 - 40 days</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >33.3%</td></tr><tr><td align="center" valign="middle" >41 - 60 days</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >27.8%</td></tr><tr><td align="center" valign="middle" >61 - 80 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >More than 80 days</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >22.2%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap></table-wrap-group></sec><sec id="s3_8"><title>3.8. Risk Factors</title><p>Although the majority of the cases were having no risk factors (38.9%), but many risk factors were detected. Of these, cardiac disease and previous neurosurgical procedures were the dominant risk factors (27.8%) (<xref ref-type="table" rid="table7">Table 7</xref>(a)).</p><p>The patient with pulmonary infection had tuberculosis. One of the patients with head trauma had Mycetoma, (6/7) patients with neurosurgical procedures were found to have infected V. P. shunt and (1/7) had EVD. (3/8) of the patients with cardiac disease had VSD, (2/8) had Fallot’s tetralogy, (1/8) had patent truncus arteriosus.</p><p>Other risk factors were detected in seven patients apart from those listed above and are distributed as follows (<xref ref-type="table" rid="table7">Table 7</xref>(b)).</p></sec><sec id="s3_9"><title>3.9. Diagnostic Tools</title><p>Both CT brain and MRI with contrast were used to diagnose brain abscess in this series however the majority of them were diagnosed with brain CT scan (83.3%) (<xref ref-type="table" rid="table8">Table 8</xref>).</p></sec><sec id="s3_10"><title>3.10. The Location of Brain Abscess</title><p>The brain abscesses were distributed in both cerebral hemispheres equally (<xref ref-type="table" rid="table9">Table 9</xref>(a)).</p><p>Most of the abscesses were detected in the frontal and parietal lobes (61.1%) (<xref ref-type="table" rid="table9">Table 9</xref>(b)). In 20% of the cases (11 cases) abscess was detected in other brain regions, half of them were in the fronto-parietal area.</p></sec><sec id="s3_11"><title>3.11. Type of Surgical Procedures</title><p>Two types of surgical procedures were used; craniotomy and burr hole with an almost equal distribution (<xref ref-type="table" rid="table1">Table 1</xref>0). The selection of either procedure depends on the size and location of brain abscess besides the surgeon preference.</p><table-wrap-group id="7"><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> (a) The distribution of risk factors among the affected groups; (b) Other risk factors detected in little number of cases</title></caption><table-wrap id="7_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Risk Factors</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Otitis Media</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >11.1%</td></tr><tr><td align="center" valign="middle" >Mastoiditis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.7%</td></tr><tr><td align="center" valign="middle" >Head Trauma</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.7%</td></tr><tr><td align="center" valign="middle" >Neurosurgical Procedure</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13.0%</td></tr><tr><td align="center" valign="middle" >Pulmonary Infection</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >Cardiac Disease</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14.8%</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13.0%</td></tr><tr><td align="center" valign="middle" >No Risk Factor</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >38.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="7_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Risk Factors</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Diabetes Mellitus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Hydrocephalus</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >42.8%</td></tr><tr><td align="center" valign="middle" >Eye Lid Abscess, Cavernous Sinus Thrombosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Postmeningitic</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >SLE</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table8" ><label><xref ref-type="table" rid="table8">Table 8</xref></label><caption><title> The imaging tools used to diagnosed brain abscess</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Diagnostic tools</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Brain CT scan with contrast</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >83.3%</td></tr><tr><td align="center" valign="middle" >Brain MRI with contrast</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >16.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap-group id="9"><label><xref ref-type="table" rid="table9">Table 9</xref></label><caption><title> (a) The location of brain abscess in cerebral hemisphere; (b) The involved brain lobes; the distribution of brain abscesses in the main lobes of the brain; (c) The other affected brain regions; other affected brain regions apart from the main brain lobes</title></caption><table-wrap id="9_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Location</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Right</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >50.0%</td></tr><tr><td align="center" valign="middle" >Left</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >50.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="9_2"><caption><title> (c)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Affected Lobe</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Frontal</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >35.2%</td></tr><tr><td align="center" valign="middle" >Parietal</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >25.9%</td></tr><tr><td align="center" valign="middle" >Temporal</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >9.3%</td></tr><tr><td align="center" valign="middle" >Occipital</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7.4%</td></tr><tr><td align="center" valign="middle" >Cerebellar</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >Other</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >20.4%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="9_3"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Affected Brain Regions</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Basal Ganglia</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.1%</td></tr><tr><td align="center" valign="middle" >Frontoparietal</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >54.5%</td></tr><tr><td align="center" valign="middle" >Frontoparietotemporal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.1%</td></tr><tr><td align="center" valign="middle" >Parietooccipital</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9.1%</td></tr><tr><td align="center" valign="middle" >Temproparietal</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >18.2%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap id="table10" ><label><xref ref-type="table" rid="table1">Table 1</xref>0</label><caption><title> The type of surgical procedure used to treat brain abscess</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Type of Surgical Procedure</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Burr Hole and Needle Aspiration</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >46.3%</td></tr><tr><td align="center" valign="middle" >Craniotomy and Excision of Membrane</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >53.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap></sec><sec id="s3_12"><title>3.12. The Microbiological Organisms Isolated in the Culture</title><p>In most of the cases (85.2%) there were no organisms separated in the culture. 8/54 cases had positive cultures, 7/8 were bacterial and only one (1/8) was fungal. (<xref ref-type="table" rid="table1">Table 1</xref>1(a)).</p><p>Only (7/54) organisms were isolated, 6 bacteria and 1 fungus. The isolated fungus was Actinomyces. The isolated bacteria were as follows (<xref ref-type="table" rid="table1">Table 1</xref>1(b)).</p><p>To better analysis the outcome of each surgical procedure and for the ease of description, the patients were divided into two groups; the craniotomy group (29/54) and the burr hole group (25/54) (<xref ref-type="table" rid="table1">Table 1</xref>0).</p></sec><sec id="s3_13"><title>3.13. Length of Antibiotic Use Postoperative</title><p>Most patients received antibiotics for 45 days in both craniotomy and burr hole groups (Tables 12(a)-(e)).</p><table-wrap-group id="11"><label><xref ref-type="table" rid="table1">Table 1</xref>1</label><caption><title> (a) The type of organism isolated in culture; (b) The specific micro-organism detected in culture</title></caption><table-wrap id="11_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Organisms Isolated</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Bacteria</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13.0%</td></tr><tr><td align="center" valign="middle" >Fungi</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.9%</td></tr><tr><td align="center" valign="middle" >No Growth</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >85.2%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="11_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bacteria Isolated</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Kelebsella</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Pesudomonas</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Staph. aureus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Partonella</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Strepto. pneumonae</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Staph. epiderms</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Strepto. viridans</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >14.3%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >100%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="12"><label><xref ref-type="table" rid="table1">Table 1</xref>2</label><caption><title> (a) and (b) The antibiotic duration length among patient underwent craniotomy and excision of membrane; (b) The antibiotic length among craniotomy group; (c)-(e) The antibiotic duration length among patient underwent burr hole and aspiration of the brain abscess; (d) and (e) The antibiotic length among burr hole group; (f) The antibiotic use among both groups</title></caption><table-wrap id="12_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >42.69</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >45.00</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >180</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >180</td></tr></tbody></table></table-wrap><table-wrap id="12_2"><caption><title> (c)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Antibiotic Duration after Craniotomy</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >0 - 15 days</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13.8%</td></tr><tr><td align="center" valign="middle" >16 - 30 days</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >31 - 45 days</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >72.4%</td></tr><tr><td align="center" valign="middle" >46 - 60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.4%</td></tr><tr><td align="center" valign="middle" >More than 60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.4%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="12_3"><caption><title> (d)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >44.40</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >45.00</td></tr><tr><td align="center" valign="middle" >Mode</td><td align="center" valign="middle" >45</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >60</td></tr></tbody></table></table-wrap><table-wrap id="12_4"><caption><title> (e)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration of Antibiotics after Burr Hole</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >30 days</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >8.0%</td></tr><tr><td align="center" valign="middle" >45 days</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >88.0%</td></tr><tr><td align="center" valign="middle" >60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="12_5"><caption><title> (f)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Antibiotic Duration after Burr Hole</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >21 - 40 days</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >8.0%</td></tr><tr><td align="center" valign="middle" >41 - 60 days</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >88.0%</td></tr><tr><td align="center" valign="middle" >More than 60</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="12_6"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Antibiotic Duration</th><th align="center" valign="middle" >Craniotomy</th><th align="center" valign="middle" >Burr Hole</th></tr></thead><tr><td align="center" valign="middle" >0 - 15 days</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >16 - 30 days</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >31 - 45 days</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >46 - 60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >More than 60 days</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >25</td></tr></tbody></table></table-wrap></table-wrap-group><p>For the ease of description both groups were gathered together and it showed nearly the same duration of antibiotic use among both groups (<xref ref-type="table" rid="table1">Table 1</xref>2(f)).</p></sec><sec id="s3_14"><title>3.14. Length of Hospital Stay</title><p>Among craniotomy group, most patients stayed in the hospital for 10 days, the minimum duration of hospital stay was 7 days and the maximum duration was 50 days (<xref ref-type="table" rid="table1">Table 1</xref>3(a))</p><p>When the durations were quoted in groups nearly half of the patients were found in the time range of 8 - 14 days (<xref ref-type="table" rid="table1">Table 1</xref>3(b)).</p><table-wrap-group id="13"><label><xref ref-type="table" rid="table1">Table 1</xref>3</label><caption><title> (a) Duration of hospital stay among craniotomy group; (b) Duration of hospital stay in groups among craniotomy group; (c) Duration of hospital stay among burr hole group; (d) Duration of hospital stay among those operated with burr hole in group; (e) The comparison of hospital stays between craniotomy and burr hole group</title></caption><table-wrap id="13_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >15.97</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >10.00</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >53</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >60</td></tr></tbody></table></table-wrap><table-wrap id="13_2"><caption><title> (c)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration of Hospital Stay after Craniotomy</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >20.7%</td></tr><tr><td align="center" valign="middle" >8 - 14 days</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >41.4%</td></tr><tr><td align="center" valign="middle" >15 - 21 days</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17.2%</td></tr><tr><td align="center" valign="middle" >More than 21 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >20.7%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="13_3"><caption><title> (d)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >15.88</th></tr></thead><tr><td align="center" valign="middle" >Median</td><td align="center" valign="middle" >10.00</td></tr><tr><td align="center" valign="middle" >Mode</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Range</td><td align="center" valign="middle" >37</td></tr><tr><td align="center" valign="middle" >Minimum</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Maximum</td><td align="center" valign="middle" >44</td></tr></tbody></table></table-wrap><table-wrap id="13_4"><caption><title> (e)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration of Hospital Stay after Burr Hole</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >24.0%</td></tr><tr><td align="center" valign="middle" >8 - 14 days</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >36.0%</td></tr><tr><td align="center" valign="middle" >15 - 21 days</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >12.0%</td></tr><tr><td align="center" valign="middle" >More than 21 days</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >28.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="13_5"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Duration of Hospital Stay</th><th align="center" valign="middle" >Craniotomy</th><th align="center" valign="middle" >Burr Hole</th></tr></thead><tr><td align="center" valign="middle" >1 - 7 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >8 - 14 days</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >15 - 21 days</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >More than 21 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >25</td></tr></tbody></table></table-wrap></table-wrap-group><p>Among burr hole group, most patients stayed for 10 days, the minimum duration among this group was 7 days and the maximum duration was 44 days (<xref ref-type="table" rid="table1">Table 1</xref>3(c) and <xref ref-type="table" rid="table1">Table 1</xref>3(d)).</p><p>When both groups were compared, those operated with craniotomy were found to have a relatively higher length of hospital stay, however no significant difference was found between both groups (<xref ref-type="table" rid="table1">Table 1</xref>3(e)).</p></sec><sec id="s3_15"><title>3.15. Early Postoperative Outcome</title><p>Early postoperative outcome was assessed in those operated on with craniotomy and it was found that the majority of the patients in this group improved or even cured completely (82.8%) (<xref ref-type="table" rid="table1">Table 1</xref>4(a)). The same was found among burr hole group; those who improved or even cured completely were 88% of the patients in this group (<xref ref-type="table" rid="table1">Table 1</xref>4(b)).</p><p>When both groups were compared, it was found that those operated with craniotomy had a high cure rate and less recurrence in comparison with burr hole group. On the other hand, Deterioration and death were significantly higher among the craniotomy group (<xref ref-type="table" rid="table1">Table 1</xref>4(c)).</p><p>Those who died (3/54) one of them had septic shock and in the remaining 2 patients the cause of death was unknown. The patient with recurrence was operated on through a burr hole and after recurrence re-operated with craniotomy and complete excision of the abscess 2 weeks later.</p><p>Most of the improvement noted was in a form of the disappearance of the presenting symptoms and therefore most of them had subsided fever, convulsions and stoppage of ear discharge (<xref ref-type="table" rid="table1">Table 1</xref>4(d)).</p></sec><sec id="s3_16"><title>3.16. The Late Outcome Results</title><p>Upon assessing the late outcome among burr hole group, it is found that almost half of the patients had complete resolution of their abscess (<xref ref-type="table" rid="table1">Table 1</xref>5(a)). On the other hand, in the craniotomy group, those who had complete evacuation of their abscesses were almost two-thirds of the patients in the group (<xref ref-type="table" rid="table1">Table 1</xref>5(b)).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>In spite of the advances made in the 20<sup>th</sup> century in the imaging techniques, microbial isolation, antibiotic therapy and surgical techniques, brain abscess (BA) still show high morbidity and mortality rates specially in the developing countries and tropical regions [<xref ref-type="bibr" rid="scirp.124459-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref18">18</xref>] . In Nathoo et al. study which constitutes the biggest series published in the literature to date with 973 brain abscess patients where they found a mean age of 24.36 years and men mostly affected 74.2%. [<xref ref-type="bibr" rid="scirp.124459-ref19">19</xref>] In this study the majority of the affected patients were in the first 2 decades of life. This may be explained by the fact that, good bulks of cases in this study were having cardiac problems and otitis media. Males were representing almost two thirds of the cases of the series as most of the attributed risk factors for developing brain abscess are affecting mainly male population. The majority</p><table-wrap-group id="14"><label><xref ref-type="table" rid="table1">Table 1</xref>4</label><caption><title> (a) The early postoperative outcome among craniotomy group; (b) The early postoperative outcome among burr hole group; (c) The comparison of the postoperative outcome among both two groups; (d) The improvement parameters among both groups</title></caption><table-wrap id="14_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Outcome and Prognosis</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Cured</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >55.2%</td></tr><tr><td align="center" valign="middle" >Improved</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >27.6%</td></tr><tr><td align="center" valign="middle" >Static</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.4%</td></tr><tr><td align="center" valign="middle" >Deteriorated</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Recurrence</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0%</td></tr><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="14_2"><caption><title> (c)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Outcome and Prognosis</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Cured</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >56.0%</td></tr><tr><td align="center" valign="middle" >Improved</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >32.0%</td></tr><tr><td align="center" valign="middle" >Static</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Deteriorated</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0%</td></tr><tr><td align="center" valign="middle" >Recurrence</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="14_3"><caption><title> (d)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Outcome and prognosis</th><th align="center" valign="middle" >Craniotomy</th><th align="center" valign="middle" >Burr Hole</th></tr></thead><tr><td align="center" valign="middle" >Cured</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Improved</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >8</td></tr><tr><td align="center" valign="middle" >Static</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Deteriorated</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Recurrence</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Died</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >25</td></tr></tbody></table></table-wrap><table-wrap id="14_4"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Improvement Parameters among Both Groups</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Headache,</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13.8%</td></tr><tr><td align="center" valign="middle" >Convulsion</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >17.2%</td></tr><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >41.4%</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13.8%</td></tr><tr><td align="center" valign="middle" >Ear Discharge</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.45%</td></tr><tr><td align="center" valign="middle" >Weakness</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.9%</td></tr><tr><td align="center" valign="middle" >Level of Consciousness</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.45%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap></table-wrap-group><table-wrap-group id="15"><label><xref ref-type="table" rid="table1">Table 1</xref>5</label><caption><title> (a) The late outcome results among burr hole group; (b) The comparison of late outcome among both craniotomy and burr hole group</title></caption><table-wrap id="15_1"><caption><title> (b)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Late Outcome among Burr Hole Group</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent %</th></tr></thead><tr><td align="center" valign="middle" >Complete evacuation</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >56.0%</td></tr><tr><td align="center" valign="middle" >Remnant</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >28.0%</td></tr><tr><td align="center" valign="middle" >Recurrence</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >12.0%</td></tr><tr><td align="center" valign="middle" >Not Done</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.0%</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100.0%</td></tr></tbody></table></table-wrap><table-wrap id="15_2"><caption><title></title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Late Outcome among Craniotomy Group</th><th align="center" valign="middle" >Craniotomy</th><th align="center" valign="middle" >Burr Hole</th></tr></thead><tr><td align="center" valign="middle" >Complete Evacuation</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >14</td></tr><tr><td align="center" valign="middle" >Remnant</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Recurrence</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >Not Done</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap></table-wrap-group><p>of patients were from Khartoum and the surrounding central area of Sudan as neurosurgical centers and facilities for established diagnosis and treating brain abscess are only available in this part of Sudan. Large number of patients was also found in the West of Sudan and this may be attributed to the poverty, illiteracy and poor sanitation created by the wars and conflicts in that region.</p><p>Due to the availability of the diagnostic tools in Khartoum and nearby states all patients were correctly diagnosed as having brain abscesses pre-operatively and the majority of the patients were abruptly operated in not more than 3 weeks from the time the diagnosis has been established. The clinical features of brain abscess is dependent on the origin of infection, site, size, number of lesions, specific brain structures involved, the anatomic disturbances to the cisterns, ventricles, and the Dural venous sinuses, and any secondary cerebral injury [<xref ref-type="bibr" rid="scirp.124459-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref21">21</xref>] . Among this series the majority of the patients presented with clinical features of raised intracranial pressure; including headache, vomiting and convulsions, or symptoms of mass effect like weakness, aphasia and decreased level of consciousness. Fever was the predominant presenting symptoms among those previously mentioned syndromes. This is similar to Nathoo’s study who reported that headaches, fever, and nuchal rigidity are the commonest clinical presentations. [<xref ref-type="bibr" rid="scirp.124459-ref19">19</xref>]</p><p>As Sudan is a wide country with the lack of neurosurgical facilities, diagnostic tools and the difficulties in transporting the patients from their sites of residency to neurosurgical centers in Khartoum, most of them presented with the duration of symptoms extending for an average of 2 months risk factors were traced in the patients in this series, one-third of the patients had no risk factors while the major risk factor seen in this study patients was neurosurgical procedures and this finding is consistent with what was mentioned in the literature.</p><p>The main imaging tool used in the diagnosis and follow-up was CT brain with contrast, as it is available in most diagnostic centers, cheap, and easily accessible.</p><p>All of the patients in this study presented in the late capsule stage and this may be explained by the late presentation of most of them.</p><p>The site of brain abscess provides an important clue on the possible causative factor. For example, abscesses from frontal and ethmoid sinusitis tend to be in the frontal lobe while those from otitis media tend to be in the temporal lobe and cerebellum. [<xref ref-type="bibr" rid="scirp.124459-ref8">8</xref>] In this series, most abscesses were found in the frontal and parietal lobes although none of the patients gave a past history of sinusitis. However, a reasonable number of patients had hydrocephalus for which the treating doctors used to do ventricular tapping from the frontal horn of the lateral ventricle to relieve the raised intracranial pressure. This may be one iatrogenic cause. The second thing is that some patients had infected ventriculoperitoneal shunt and retrograde spread of infection may be considered as another cause for this. Besides that, the bulk of patients had congenital heart diseases as a predisposing factor, and this causes brain abscess through haematogenous spread and abscesses tend to be distributed mainly among frontal, parietal and temporal lobes.</p><p>Some patients were operated on through burr hole and some through craniotomy. To avoid any bias in evaluating which is better, the number of patients in both groups was almost 50:50, and all patients in both groups were offered the same antibiotics (Ceftriaxone, Vancomycin and Metronidazole) and for the same length of antibiotic use. In Nathoo et al. series (the biggest reported series) found that the commonest organisms isolated S. aureus and S. epidermis [<xref ref-type="bibr" rid="scirp.124459-ref22">22</xref>] Most of the patients in this study series had negative cultures and no organisms isolated owing to the pre-operative empiric use of antibiotics. Most of the isolated micro-organisms were bacterial and this may be due to the fact that most of the patients had neurosurgical procedures, congenital heart diseases and otitis media as the main predisposing factors for their brain abscesses.</p><p>Craniotomy patients in this study required relatively longer hospitalization as craniotomy is more invasive procedure and the patient requires closer monitoring in the intensive care unit and in the ward prior to discharge. Few of the burr hole patients required long hospitalization as their clinical condition didn’t improve postoperatively and some of them required re-operation with craniotomy and evacuation of their abscesses. This is unlike what has been mentioned in Mut et al. 2009, Tan et al. 2010 and Sarmast et al. 2012 series in which they reported that craniotomy patients significantly have shorter hospital stay and duration of antibiotic use when compared with burr hole group [<xref ref-type="bibr" rid="scirp.124459-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref25">25</xref>] . This can be simply justified with the fact that in this study we fixed the duration of antibiotic use for both groups to avoid any bias in the outcome as mentioned earlier.</p><p>Upon assessing the early outcome among both groups, it has been found that craniotomy patients have relatively higher recovery rates with no recurrences while on the other hand death and neurologic deterioration were higher in this group when compared with burr hole group. This may be justified by the reason that craniotomy is more aggressive and needs some manipulation of the brain tissue close to the abscess. The fact that the craniotomy group has fewer recurrences and a lower rate of surgeries is consistent with the findings in Mut et al. and Sarmast et al. studies. [<xref ref-type="bibr" rid="scirp.124459-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.124459-ref10">10</xref>] However when the overall outcome among the craniotomy group and burr hole group was found that there is no difference between both groups (P = 0.000). The patients among both groups were re-evaluated with CT brain with contrast in a mean duration of 4 months, and it has been found that no significant difference between both groups when talking in terms of long-term follow-up.</p></sec><sec id="s5"><title>5. Conclusions</title><p>Brain abscess is still a challenging neurosurgical condition for most neurosurgeons in Sudan. The limited number of Sudanese neurosurgeons, neurosurgical centers and diagnostic facilities contributed to the delay in diagnosing brain abscess in most cases.</p><p>CT brain with contrast is a good imaging tool for assessing the size, site and stage of brain abscesses</p><p>The empiric uses of antibiotics pre-operatively aided to an increased prevalence of insignificant microorganism’s growth in most specimens. Therefore, we recommend taking a biopsy of the brain abscess early before the antibiotic prescription. It is also important to check aerobes and anaerobes, gram staining and fungal growth in any brain abscess culture rather than just doing the routine bacterial culture only.</p><p>No difference between craniotomy or burr hole for removal of brain abscesses in terms of antibiotic use or duration of hospital stay. However, burr hole aspiration is associated with higher rates of recurrences. On the other hand, craniotomy and excision have relatively higher neurologic morbidity postoperative with expectantly higher post-operative hospitalization. Therefore, the selection of surgical technique should be individualized in each case based on the abscess site size source patient fitness for surgery and the neurosurgeon’s preference.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Ali, B.S.H., Ahmed, A.D.S., Elzain, M.A. and Abdelradi, F.E.M. (2023) Brain Abscess Surgery Outcome: A Comparison between Craniotomy with Membrane Excision versus Burr Hole Aspiration. Open Journal of Modern Neurosurgery, 13, 74-93. https://doi.org/10.4236/ojmn.2023.132010</p></sec><sec id="s8"><title>Abbreviations</title><p>CHD—Cyanotic Heart Disease</p><p>MCA—Middle Cerebral Artery</p><p>HIV—Human Immunodeficiency Virus</p><p>CT—Computed Tomography</p><p>MRI—Magnetic Resonance Image</p><p>MHC—Major Histocompatibility Complex</p><p>IL 1—Interleukin 1</p><p>TNF—Tumour Necrosis Factor</p><p>CNS—Central Nervous System</p><p>MIP 2—Macrophage Inflammatory Protein 2</p><p>ICP—Intra Cranial Pressure</p><p>T1—Time 1</p><p>T2—Time 2</p><p>T1WI—Time 1 Weighted Image</p><p>T2WI—Time 2 Weighted Image</p><p>PCR—Polymerase Chain Reaction</p><p>DWI—Diffusion Weighted Image</p><p>ADC—Apparent Diffusion Coefficient</p><p>FA—Fractional Anisotropy</p><p>PMR—Perfusion Magnetic Resonance</p><p>MRS—Magnetic Resonance Spectroscopy</p><p>1HMRS—Proton Magnetic Resonance Spectroscopy</p><p>rCBV—relative Cerebral Blood Volume</p><p>LP—Lumbar Puncture</p><p>CSF—Cerebro-Spinal Fluid</p><p>ESR—Erythrocytes Sedimentation Rate</p><p>SD—Standard Deviation</p><p>NCNS—National Centre for Neurological Sciences</p><p>Fig—Figure</p><p>OM—Otitis Media</p><p>VP—Ventriculo-Peritoneal</p><p>EVD—External Ventricular Drain</p><p>VSD—Ventricular Septal Defect</p><p>SLE—Systemic Lupus Erythematosus</p><p>BA—Brain Abscess</p><p>SPSS—Statistical Package for the Social Sciences</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124459-ref1"><label>1</label><mixed-citation publication-type="book" xlink:type="simple">Loftus, C.M., Osenbach, R.K. and Biller, J. (1996) Diagnosis and Management of Brain Abscess. In: Wilkins, R.H. and Rengachary, S.S., Eds., Neurosurgery, McGraw-Hill, New York, 3285-3298.</mixed-citation></ref><ref id="scirp.124459-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, B.S., Gupta, S.K. and Khosla, V.K. (2000) Current Concepts in the Management of Pyogenic Brain Abscess. Neurology India, 48, 105-111.</mixed-citation></ref><ref id="scirp.124459-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Lu, C.H., Chang, W.N. and Lui, C.C. (2006) Strategies for the Management of Bacterial Brain Abscess. Journal of Clinical Neuroscience, 13, 979-985. https://doi.org/10.1016/j.jocn.2006.01.048</mixed-citation></ref><ref id="scirp.124459-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Takeshita, M., Kagawa, M., Izawa, M. and Takakura, K. (1998) Current Treatment Strategies and Factors Influencing Outcome in Patients with Bacterial Brain Abscess. Acta Neurochirurgica, 140, 1263-1270. https://doi.org/10.1007/s007010050248</mixed-citation></ref><ref id="scirp.124459-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Tekk&amp;#246;k, I.H. and Erbengi, A. (1992) Management of Brain Abscess in Children. Review of 130 Cases over a Period of 21 Years. Child’s Nervous System, 8, 411-416. https://doi.org/10.1007/BF00304791</mixed-citation></ref><ref id="scirp.124459-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yang, S.Y. (1981) Brain Abscess: A Review of 400 Cases. Journal of Neurosurgery, 55, 794-799. https://doi.org/10.3171/jns.1981.55.5.0794</mixed-citation></ref><ref id="scirp.124459-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kao, P.T., Tseng, H.K., Liu, C.P., Su, S.C. and Lee, C.M. (2003) Brain Abscess: Clinical Analysis of 53 Cases. Journal of Microbiology, Immunology and Infection, 36, 129-136.</mixed-citation></ref><ref id="scirp.124459-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Xiao, F., Tseng, M.Y., Teng, L.J., Tseng, H.M. and Tsai, J.C. (2005) Brain Abscess: Clinical Experience and Analysis of Prognostic Factors. Surgical Neurology, 63, 442-450. https://doi.org/10.1016/j.surneu.2004.08.093</mixed-citation></ref><ref id="scirp.124459-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Osenbach, R.K. and Loftus, C.M. (1992) Diagnosis and Management of Brain Abscess. Neurosurgery Clinics of North America, 3, 403-420. https://doi.org/10.1016/S1042-3680(18)30671-5</mixed-citation></ref><ref id="scirp.124459-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ciurea, A.V., Stoica, F., Vasilescu, G. and Nuteanu, L. (1999) Neurosurgical Management of Brain Abscesses in Children. Child’s Nervous System, 15, 309-317. https://doi.org/10.1007/s003810050400</mixed-citation></ref><ref id="scirp.124459-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Szuwart, U. and Bennefeld, H. (1990) Bacteriological Analysis of Pyogenic Infections of the Brain. Neurosurgical Review, 13, 113-118. https://doi.org/10.1007/BF00383651</mixed-citation></ref><ref id="scirp.124459-ref12"><label>12</label><mixed-citation publication-type="book" xlink:type="simple">Britt, R.H. (1985) Brain Abscess. In: Wilkins, R.H. and Rengachary, S.S., Eds., Neurosurgery, McGraw-Hill, New York, 1928-1956.</mixed-citation></ref><ref id="scirp.124459-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Carpenter, J., Stapleton, S. and Holliman, R. (2007) Retrospective Analysis of 49 Cases of Brain Abscessand Review of the Literature. European Journal of Clinical Microbiology &amp; Infectious Diseases, 26, 1-11. https://doi.org/10.1007/s10096-006-0236-6</mixed-citation></ref><ref id="scirp.124459-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Goodkin, H.P., Harper, M.B. and Pomeroy, S.L. (2004) Intracerebral Abscess in Children: Historical Trendsat Children’s Hospital Boston. Pediatrics, 113, 1765-1770. https://doi.org/10.1542/peds.113.6.1765</mixed-citation></ref><ref id="scirp.124459-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">McCaig, L.F., Besser, R.E. and Hughes, J.M. (2002) Trends in Antimicrobial Prescribing Rates for Children and Adolescents. JAMA, 287, 3096-3102. https://doi.org/10.1001/jama.287.23.3096</mixed-citation></ref><ref id="scirp.124459-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Menon, S., Bharadwaj, R., Chowdhary, A., Kaundinya, D.V. and Palande, D.A. (2008) Current Epidemiology of Intracranial Abscesses: A Prospective 5 Year Study. Journal of Medical Microbiology, 57, 1259-1268. https://doi.org/10.1099/jmm.0.47814-0</mixed-citation></ref><ref id="scirp.124459-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wiwanitkit, S. and Wiwanitkit, V. (2012) Pyogenic Brain Abscess in Thailand. North American Journal of Medical Sciences, 4, 245-248. https://doi.org/10.4103/1947-2714.97200</mixed-citation></ref><ref id="scirp.124459-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Kaczorowska, B., Chmielewski, H., Pawelczyk, M., Przybyla, M., Blaszczyk, B. and Chudzik, W. (2007) The Case of Multiple Brain Abscesses Conservatively Treated. Polski Merkuriusz Lekarski, 22, 150-153.</mixed-citation></ref><ref id="scirp.124459-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Nathoo, N., Nadvi, S.S., Narotam, P.K. and van Dellen, J.R. (2011) Brain Abscess: Management and Outcome Analysis of a Computed Tomography Era Experience with 973 Patients. World Neurosurgery, 75, 716-726. https://doi.org/10.1016/j.wneu.2010.11.043</mixed-citation></ref><ref id="scirp.124459-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Chun, C.H., Johnson, J.D., Hofstetter, M. and Raff, M.J. (1986) Brain Abscess. A Study of 45 Consecutive Cases. Medicine, 65, 415-431. https://doi.org/10.1097/00005792-198611000-00006</mixed-citation></ref><ref id="scirp.124459-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Arlotti, M., Grossi, P., Pea, F., et al. (2010) Consensus Document on Controversial Issues for the Treatment of Infections of the Central Nervous System: Bacterial Brain Abscesses. International Journal of Infectious Diseases, 14, S79-S92. https://doi.org/10.1016/j.ijid.2010.05.010</mixed-citation></ref><ref id="scirp.124459-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mathisen, G.E. and Johnson, J.P. (1997) Brain Abscess. Clinical Infectious Diseases, 25, 763-779. https://doi.org/10.1086/515541</mixed-citation></ref><ref id="scirp.124459-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Seydoux, C. and Francioli, P. (1992) Bacterial Brain Abscesses. Factors Influencing Mortality and Sequelae. Clinical Infectious Diseases, 15, 394-401. https://doi.org/10.1093/clind/15.3.394</mixed-citation></ref><ref id="scirp.124459-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Mamelak, A.N., Mampalam, T.J., Obana, W.G. and Rosenblum, M.L. (1995) Improved Management of Multiple Brain Abscesses: A Combined Surgical and Medical Approach. Neurosurgery, 36, 76-86. https://doi.org/10.1227/00006123-199501000-00010</mixed-citation></ref><ref id="scirp.124459-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Rosenblum, M.L., Mampalam, T.J. and Pons, V.G. (1986) Controversies in the Management of Brain Abscesses. Clinical Neurosurgery, 33, 603-632.</mixed-citation></ref></ref-list></back></article>